These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36184403)

  • 1. Establishment of a model to assess mumps virus neurovirulence in neonatal Wistar rats.
    Ruan J; Dong W; Liu Y; Zhang Y; Niu B; Chen Q; Fu Z; Zhu F; An Q; Tian D
    Vaccine; 2022 Oct; 40(44):6397-6403. PubMed ID: 36184403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence.
    Lemon K; Rima BK; McQuaid S; Allen IV; Duprex WP
    J Virol; 2007 Aug; 81(15):8293-302. PubMed ID: 17475640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study.
    Rubin SA; Afzal MA; Powell CL; Bentley ML; Auda GR; Taffs RE; Carbone KM
    J Infect Dis; 2005 Apr; 191(7):1123-8. PubMed ID: 15747248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain.
    Rubin SA; Pletnikov M; Carbone KM
    J Virol; 1998 Oct; 72(10):8037-42. PubMed ID: 9733843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype.
    Rubin SA; Amexis G; Pletnikov M; Li Z; Vanderzanden J; Mauldin J; Sauder C; Malik T; Chumakov K; Carbone KM
    J Virol; 2003 Nov; 77(21):11616-24. PubMed ID: 14557647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-specific contributions to mumps virus neurovirulence and neuroattenuation.
    Sauder CJ; Zhang CX; Ngo L; Werner K; Lemon K; Duprex WP; Malik T; Carbone K; Rubin SA
    J Virol; 2011 Jul; 85(14):7059-69. PubMed ID: 21543475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative evaluation of Leningrad-3 mumps vaccine virus neurovirulence in a neonatal rat model].
    Ignat'ev GM; Otrashevskaia EV; Rubin SA
    Vopr Virusol; 2011; 56(4):30-3. PubMed ID: 21899067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of population diversity on neurovirulence potential of plaque purified L-Zagreb variants.
    Ivancic-Jelecki J; Forcic D; Jagusic M; Kosutic-Gulija T; Mazuran R; Balija ML; Isakov O; Shomron N
    Vaccine; 2016 Apr; 34(20):2383-9. PubMed ID: 27013432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurovirulence safety testing of mumps vaccines--historical perspective and current status.
    Rubin SA; Afzal MA
    Vaccine; 2011 Apr; 29(16):2850-5. PubMed ID: 21334386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains.
    Rubin SA; Snoy PJ; Wright KE; Brown EG; Reeve P; Beeler JA; Carbone KM
    J Infect Dis; 1999 Aug; 180(2):521-5. PubMed ID: 10395874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurovirulence of mumps virus: intraspinal inoculation test in marmosets.
    Saika S; Kidokoro M; Aoki A; Ohkawa T
    Biologicals; 2004 Sep; 32(3):147-52. PubMed ID: 15536045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Single Point Mutation in the Mumps V Protein Alters Targeting of the Cellular STAT Pathways Resulting in Virus Attenuation.
    Malik T; Ngo L; Bosma T; Rubin S
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31683999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans.
    Rubin SA; Pletnikov M; Taffs R; Snoy PJ; Kobasa D; Brown EG; Wright KE; Carbone KM
    J Virol; 2000 Jun; 74(11):5382-4. PubMed ID: 10799619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity.
    Sauder CJ; Vandenburgh KM; Iskow RC; Malik T; Carbone KM; Rubin SA
    Virology; 2006 Jun; 350(1):48-57. PubMed ID: 16494912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology, pathogenesis and pathology of mumps virus.
    Rubin S; Eckhaus M; Rennick LJ; Bamford CG; Duprex WP
    J Pathol; 2015 Jan; 235(2):242-52. PubMed ID: 25229387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence.
    Sauder CJ; Zhang CX; Link MA; Duprex WP; Carbone KM; Rubin SA
    Vaccine; 2009 Sep; 27(42):5822-9. PubMed ID: 19660591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular epidemiology of mumps virus.
    Mühlemann K
    Infect Genet Evol; 2004 Sep; 4(3):215-9. PubMed ID: 15450201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of an efficient reverse genetic system of Mumps virus S79 from cloned DNA.
    Zhou D; Zhu MY; Wang YL; Hao XQ; Zhou DM; Liu RX; Zhang CD; Qu CF; Zhao ZY
    World J Pediatr; 2019 Oct; 15(5):499-505. PubMed ID: 31456156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant mumps viruses expressing the batMuV fusion glycoprotein are highly fusion active and neurovirulent.
    Krüger N; Sauder C; Hoffmann M; Örvell C; Drexler JF; Rubin S; Herrler G
    J Gen Virol; 2016 Nov; 97(11):2837-2848. PubMed ID: 27590163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and development of a promising novel mumps vaccine candidate strain.
    Liang Y; Ma S; Liu L; Zhao H; Wang L; Jiang L; Xie Z; Dong C; Li Q
    Microbes Infect; 2010 Dec; 12(14-15):1178-87. PubMed ID: 20800105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.